trending Market Intelligence /marketintelligence/en/news-insights/trending/Ef3kY81bsAW10aPJ4hh7kA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Outlook Therapeutics to implement 1-for-8 reverse stock split

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Outlook Therapeutics to implement 1-for-8 reverse stock split

Outlook Therapeutics Inc.'s board approved a 1-for-8 reverse split of its common stock.

The Cranbury, N.J.-based biopharmaceutical company's common shares will begin trading on a reverse split-adjusted basis from March 18 on the Nasdaq Capital Market.

Outlook's shareholders have already approved the plan.

American Stock Transfer & Trust Co. LLC, which is the company's transfer agent, is acting as the exchange agent for the stock split.